Chung-Shien Lee

18PUBLICATIONS
6CO-AUTHORS
Molecular targetsMetabolic medicineAutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Nov 09, 2023
Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.

Madison Fraser, Nagashree Seetharamu, Matthew Diamond

|Feb 06, 2023
A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer.

Chung-Shien Lee, So Yi Lam, Angel Liu

|Jan 06, 2023
Alectinib-induced hemolytic anemia.

Chung-Shien Lee, Kevin Sullivan

|Sep 22, 2022
Inpatient utilization of immune checkpoint inhibitors and clinical outcomes.

Jonathan Wang, Chung-Shien Lee, Shirin Attarian

|Apr 19, 2022
A Real World Perspective of PARP Inhibitor Use in Gynecological Cancer Patients.

Chung-Shien Lee, Jennifer Hernandez, Connie Liang

|Oct 19, 2021
A deep dive into CDK4/6 inhibitors: Evaluating real world toxicities and treatment paradigms in the elderly population.

Coral Olazagasti, Chung-Shien Lee, Angel Liu

Pageof 3

Frequent Collaborators

4 joint publications

Nagashree Seetharamu

3 joint publications

Angel W Liu

1 joint publications

Stephen Eng

1 joint publications

Kevin Y Wang